CHANGXIN LI

Prof. CHANGXIN LI

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2020 in Physical Therapy Research
Verified
Journal Article
Closed access
PDF file
SIShota Inoue
Shota Inoue
HMHideki Moriyama
Hideki Moriyama
YWYoshio Wakimoto
Yoshio Wakimoto
CHANGXIN LICHANGXIN LI
CHANGXIN LI
JHJunpei Hatakeyama
Junpei Hatakeyama
TAToshihiro Akisue
Toshihiro Akisue
Objective: Joint contractures are a major complication following joint immobilization. However, no fully effective treatment has yet been found. Recently, carbon dioxide (CO2) therapy was developed and verified this therapeutic application in various disorders. We aimed to verify the efficacy of transcutaneous CO2 therapy for immobilization-induced joint contracture. Method: Twenty-two Wistar rats were randomly assigned to three groups: caged control, those untreated after joint immobilization, and those treated after joint immobilization. The rats were treated with CO2 for 20 min once a daily either during immobilization, (prevention) or during remobilization after immobilization (treatment). Knee extension motion was measured with a goniometer, and the muscular and articular factors responsible for contractures were calculated. We evaluated muscle fibrosis, fibrosis-related genes (collagen Type 1α1 and TGF-β1) in muscles, synovial intima's length, and fibrosis-related proteins (Type I collagen and TGF-β1) in the joint capsules. Results: CO2 therapy for prevention and treatment improved the knee extension motion. Muscular and articular factors decreased in rats of the treatment group. The muscular fibrosis of treated rats decreased in the treatment group. Although CO2 therapy did not repress the increased expression of collagen Type 1α1, the therapy decreased the expression of TGF-β1 in the treatment group. CO2 therapy for treatment improved the shortening of the synovial membrane after immobilization and decreased the immunolabeling of TGF-β1 in the joint capsules. Conclusions: CO2 therapy may prevent and treat contractures after joint immobilization, and appears to be more effective as a treatment strategy for the deterioration of contractures during remobilization.

10 April 2023 in The Journal of Physiology
Verified
Journal Article
Closed access
PDF file
CHANGXIN LICHANGXIN LI
CHANGXIN LI
SIShota Inoue
Shota Inoue
JHJunpei Hatakeyama
Junpei Hatakeyama
HJHanlin Jiang
Hanlin Jiang
DTDaisuke Takamura
Daisuke Takamura
HMHideki Moriyama
Hideki Moriyama

22 October 2025 in Bone & Joint Research
Verified
Journal Article
Open access
PDF file
CHANGXIN LICHANGXIN LI
CHANGXIN LI
HMHideki Moriyama
Hideki Moriyama
SIShota Inoue
Shota Inoue
JHJunpei Hatakeyama
Junpei Hatakeyama
DTDaisuke Takamura
Daisuke Takamura
TAToshihiro Akisue
Toshihiro Akisue
Aims: As global ageing and life expectancy increase, the prevalence and incidence of osteoarthritis (OA) are expected to rise. Transcutaneous carbon dioxide (CO 2 ) therapy has been shown to promote muscle regeneration, fracture healing, strengthen athletic endurance, and aid recovery from peripheral nerve damage and cancer. However, its effect on symptom modification and inflammation in OA is largely unknown. This study aimed to examine whether CO 2 therapy could slow the progression of OA and relieve OA-related inflammation in a chemically or surgically induced model in rats. Methods: OA model was induced in 32 nine-week-old male Wistar rats by intra-articular injection of monosodium iodoacetate (MIA) and surgically induced by destabilization of the medial meniscus (DMM) in the knee joint. The pathogenesis period of MIA was set at two weeks, and for DMM at four weeks. After the creation of the OA model, either CO 2 therapy or sham intervention was applied daily for 20 minutes, and treatment was applied at two weeks. Behavioural assessments were completed at the end of the intervention period, and then knee joints were harvested. Non-demineralized frozen sections were prepared, and samples were examined histologically. Results: Assessments of knee joint diameter showed that knee swelling in the DMM model improved significantly after two weeks of CO 2 therapy compared to the control group. The histomorphometric evaluation showed a significant increase in chondrocyte density in the CO 2 group compared to the MIA and DMM groups. Furthermore, the number of matrix metalloproteinase 13 (MMP13), a disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAMTS5), and proinflammatory cytokines tumour necrosis factor-α (TNF-α), interleukin (IL)-1β, and IL-6 positive cells decreased in the CO 2 group. In contrast, the number of aggrecan and type II collagen-positive cells increased. Conclusion: Our results demonstrate that transcutaneous CO 2 therapy improves OA-related inflammation and suppresses the degeneration of articular cartilage. Cite this article: Bone Joint Res 2025;14(10):888–900.

29 April 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
SZShengxi Zhang
Shengxi Zhang
JHJinXi Huang
JinXi Huang
XLXiaoming Li
Xiaoming Li
ZZZiling Zhou
Ziling Zhou
SBShichang Bai
Shichang Bai
CHANGXIN LICHANGXIN LI
CHANGXIN LI
Background: Tectoridin is a prominent isoflavone glycoside found in herbs such as Belamcanda chinensis (L.) DC and Iris tectorum Maxim. It has drawn increasing research interest due to its promising pharmacological activities. However, no critical review to date has determined whether its broad pharmacological activity stems from binding to specific targets or from the non-specific, broad-spectrum activity commonly associated with flavonoids. This paper provides a comprehensive review of tectoridin, covering its plant sources, pharmacological effects, pharmacokinetics, and toxicity, alongside an in-depth analysis of the mechanisms underlying its pharmacological effects and strategic recommendations for advancing its clinical translation. Methods: A systematic literature search was conducted in PubMed, Web of Science, Google Scholar, SciFinder, and CNKI for publications from 1968 to 2025 using keywords including tectoridin, tectorigenin 7-O-glucoside, traditional uses, ethnopharmacology, pharmacology, bioactive compounds, biological activity, pharmacokinetics and toxicity. Results: Tectoridin exhibits a broad spectrum of pharmacological activities, including anticancer, anti-inflammatory, hepatoprotective, antidiabetic, antioxidant, cardiovascular, and estrogenic effects. Pharmacokinetic studies have shown rapid tissue distribution and slow elimination; the aglycone metabolite tectorigenin often displays enhanced bioactivity, and chemical modifications may further improve efficacy. Toxicity data suggest relative safety in medicinal food contexts, but comprehensive in vivo studies remain limited. Tectoridin shows promise for treating cancer and inflammatory diseases; however, further research is needed to elucidate its molecular mechanisms, clarify toxicity, and optimize bioactivity. Conclusions: This review bridges natural products and modern therapeutics by focusing on tectoridin, highlighting its therapeutic potential, addressing challenges, and offering new perspectives for treating various diseases.